FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948743826> ?p ?o ?g. }

• W2948743826 endingPage "1213" @default.
• W2948743826 startingPage "1202" @default.
• W2948743826 abstract "Abstract Objective To investigate whether the early administration of intravenous second‐line immunotherapy correlates with improved long‐term cognition and the potential mechanisms via imaging in adult patients with moderate‐to‐severe anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. Methods Sixteen adult patients with moderate‐to‐severe anti‐NMDA receptor encephalitis past the acute stage and 15 healthy controls (HCs) performed a set of comprehensive neuropsychological tests, and underwent a resting‐state fMRI study to analyze resting state functional connectivity (FC). In addition, correlation analyses were performed between hippocampal FC and cognitive performance. All patients were received intravenous first‐line immunotherapy, and nine of them were also given intravenous second‐line immunotherapy within 3 months of disease onset. Results The patients who only received first‐line immunotherapy showed significant verbal episodic memory impairments compared with HCs and those who received second‐line immunotherapy, while no significant differences were noted between the patients with second‐line immunotherapy and the HCs. In line with the results of neuropsychological tests, significant changes in bilateral hippocampal FC were observed in the patients who only received first‐line immunotherapy compared with both HCs and those who received second‐line immunotherapy. However, no significant differences in hippocampal FC were observed in the patients with second‐line immunotherapy compared with the HCs. Importantly, hippocampal‐medial prefrontal cortex (mPFC) connectivity positively correlated with memory performance. Interpretation In the long term, early administration of intravenous second‐line immunotherapy may be associated with more favorable verbal episodic memory outcomes in patients with moderate‐to‐severe anti‐NMDA receptor encephalitis. These results may provide some evidence and guidance for the use of immunotherapy in this population." @default.
• W2948743826 created "2019-06-14" @default.
• W2948743826 creator A5005388444 @default.
• W2948743826 creator A5016201567 @default.
• W2948743826 creator A5020166704 @default.
• W2948743826 creator A5022681712 @default.
• W2948743826 creator A5032912960 @default.
• W2948743826 creator A5050517085 @default.
• W2948743826 creator A5064807572 @default.
• W2948743826 creator A5085381594 @default.
• W2948743826 date "2019-06-09" @default.
• W2948743826 modified "2023-10-14" @default.
• W2948743826 title "Early second‐line therapy is associated with improved episodic memory in anti‐NMDA receptor encephalitis" @default.
• W2948743826 cites W1760829075 @default.
• W2948743826 cites W1913608598 @default.
• W2948743826 cites W1964877394 @default.
• W2948743826 cites W2051552021 @default.
• W2948743826 cites W2075105655 @default.
• W2948743826 cites W2079082269 @default.
• W2948743826 cites W2084675291 @default.
• W2948743826 cites W2087363103 @default.
• W2948743826 cites W2106080677 @default.
• W2948743826 cites W2118067546 @default.
• W2948743826 cites W2124919192 @default.
• W2948743826 cites W2131596619 @default.
• W2948743826 cites W2143285014 @default.
• W2948743826 cites W2144683025 @default.
• W2948743826 cites W2146199022 @default.
• W2948743826 cites W2148230634 @default.
• W2948743826 cites W2163022996 @default.
• W2948743826 cites W2182128059 @default.
• W2948743826 cites W2280783985 @default.
• W2948743826 cites W2623549309 @default.
• W2948743826 cites W2752533717 @default.
• W2948743826 doi "https://doi.org/10.1002/acn3.50798" @default.
• W2948743826 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6649545" @default.
• W2948743826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31353868" @default.
• W2948743826 hasPublicationYear "2019" @default.
• W2948743826 type Work @default.
• W2948743826 sameAs 2948743826 @default.
• W2948743826 citedByCount "14" @default.
• W2948743826 countsByYear W29487438262019 @default.
• W2948743826 countsByYear W29487438262020 @default.
• W2948743826 countsByYear W29487438262021 @default.
• W2948743826 countsByYear W29487438262022 @default.
• W2948743826 countsByYear W29487438262023 @default.
• W2948743826 crossrefType "journal-article" @default.
• W2948743826 hasAuthorship W2948743826A5005388444 @default.
• W2948743826 hasAuthorship W2948743826A5016201567 @default.
• W2948743826 hasAuthorship W2948743826A5020166704 @default.
• W2948743826 hasAuthorship W2948743826A5022681712 @default.
• W2948743826 hasAuthorship W2948743826A5032912960 @default.
• W2948743826 hasAuthorship W2948743826A5050517085 @default.
• W2948743826 hasAuthorship W2948743826A5064807572 @default.
• W2948743826 hasAuthorship W2948743826A5085381594 @default.
• W2948743826 hasBestOaLocation W29487438261 @default.
• W2948743826 hasConcept C118552586 @default.
• W2948743826 hasConcept C126322002 @default.
• W2948743826 hasConcept C14216870 @default.
• W2948743826 hasConcept C143998085 @default.
• W2948743826 hasConcept C148762608 @default.
• W2948743826 hasConcept C169900460 @default.
• W2948743826 hasConcept C170493617 @default.
• W2948743826 hasConcept C203014093 @default.
• W2948743826 hasConcept C2777701055 @default.
• W2948743826 hasConcept C2780211071 @default.
• W2948743826 hasConcept C67018056 @default.
• W2948743826 hasConcept C71924100 @default.
• W2948743826 hasConcept C88576662 @default.
• W2948743826 hasConcept C8891405 @default.
• W2948743826 hasConceptScore W2948743826C118552586 @default.
• W2948743826 hasConceptScore W2948743826C126322002 @default.
• W2948743826 hasConceptScore W2948743826C14216870 @default.
• W2948743826 hasConceptScore W2948743826C143998085 @default.
• W2948743826 hasConceptScore W2948743826C148762608 @default.
• W2948743826 hasConceptScore W2948743826C169900460 @default.
• W2948743826 hasConceptScore W2948743826C170493617 @default.
• W2948743826 hasConceptScore W2948743826C203014093 @default.
• W2948743826 hasConceptScore W2948743826C2777701055 @default.
• W2948743826 hasConceptScore W2948743826C2780211071 @default.
• W2948743826 hasConceptScore W2948743826C67018056 @default.
• W2948743826 hasConceptScore W2948743826C71924100 @default.
• W2948743826 hasConceptScore W2948743826C88576662 @default.
• W2948743826 hasConceptScore W2948743826C8891405 @default.
• W2948743826 hasFunder F4320321001 @default.
• W2948743826 hasFunder F4320321106 @default.
• W2948743826 hasIssue "7" @default.
• W2948743826 hasLocation W29487438261 @default.
• W2948743826 hasLocation W29487438262 @default.
• W2948743826 hasLocation W29487438263 @default.
• W2948743826 hasLocation W29487438264 @default.
• W2948743826 hasOpenAccess W2948743826 @default.
• W2948743826 hasPrimaryLocation W29487438261 @default.
• W2948743826 hasRelatedWork W1051312076 @default.
• W2948743826 hasRelatedWork W1969998900 @default.
• W2948743826 hasRelatedWork W1983251249 @default.
• W2948743826 hasRelatedWork W2079315320 @default.
• W2948743826 hasRelatedWork W2110468955 @default.

• next